— Know what they know.
Not Investment Advice
Also trades as: 0J6Z.L (LSE) · $vol 0M

HUM NYSE

Humana Inc.
1W: -2.9% 1M: +6.5% 3M: +13.5% YTD: +56.9% 1Y: +42.7% 3Y: -18.5% 5Y: -2.5%
$414.85
-2.37 (-0.57%)
 
Weekly Expected Move ±7.5%
$359 $391 $422 $454 $485
NYSE · Healthcare · Medical - Healthcare Plans · Tech Score Buy · Power 62 · $49.8B mcap · 120M float · 1.15% daily turnover · Short 44% of daily vol
Credit Risk of going bust: higher than 55% of companies Debt: 22.2% of company value Bonds: $472.8M held by 522 funds, 111 bp over Treasuries → details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $12.43 (down 97%), Humana Inc. would be worth roughly what it owes.
Total debt $14.25B against a stock market value of $49.82B.
Distance to default 4.64 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $8.26B (short-term plus half of long-term), stock volatility 47.5%; Altman Z'' 4.52. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.

Balance Sheet Trends

Total Assets
$48.8B +5.3% ▲
5Y CAGR: +6.9%
Total Liabilities
$31.0B +3.8% ▲
5Y CAGR: +7.9%
Shareholders Equity
$17.7B +7.8% ▲
5Y CAGR: +5.2%
Cash & Investments
$4.2B +89.1% ▲
5Y CAGR: -2.1%
Total Debt
$12.9B +5.5% ▲
5Y CAGR: +16.4%
Net Debt
$8.7B -13.0% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$3.4B$5.1B$4.7B$2.2B$4.2B
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$3.4B$5.1B$4.7B$2.2B$4.2B
Net Receivables$1.8B$1.7B$2.0B$2.7B$3.3B
Inventory$0$0$0$0$0
Other Current Assets-$18.4B-$20.6B-$23.4B-$23.1B$0
Total Current Assets$0$0$0$0$7.5B
Property, Plant & Equip.$3.8B$3.7B$3.5B$3.0B$2.7B
Goodwill & Intangibles$13.7B$10.9B$11.2B$11.1B$10.8B
Long-Term Investments$0$0$0$0$16.8B
Other Non-Current Assets-$18.1B-$15.5B-$14.8B-$14.3B$10.8B
Total Non-Current Assets$0$0$0$0$41.3B
Total Assets$44.4B$43.1B$47.1B$46.5B$48.8B
— Liabilities —
Accounts Payable$0$0$0$0$9.8B
Short-Term Debt$0$0$0$0$150M
Deferred Revenue$0$0$0$0$356M
Other Current Liabilities$0$0$0$0$0
Total Current Liabilities$0$0$0$0$10.3B
Long-Term Debt$10.5B$9.0B$10.2B$11.1B$12.4B
Other Non-Current Liab.$17.7B$18.7B$20.5B$18.9B$7.9B
Total Non-Current Liabilities$28.3B$27.7B$30.7B$30.0B$20.7B
Total Liabilities$28.3B$27.7B$30.7B$30.0B$31.0B
— Equity —
Common Stock$33M$33M$33M$33M$33M
Retained Earnings$23.1B$25.5B$27.5B$28.3B$29.1B
Accumulated OCI$42M-$1.3B-$999M-$1.1B-$633M
Total Stockholders Equity$16.1B$15.3B$16.3B$16.4B$17.7B
Total Liabilities & Equity$44.4B$43.1B$47.1B$46.5B$48.8B
— Key Metrics —
Total Debt$10.5B$9.0B$10.2B$11.1B$12.9B
Net Debt$7.1B$4.0B$5.5B$8.9B$8.7B
Total Investments$0$0$0$0$16.8B

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms